Cargando…
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently available hints that both new-onset hyperglycemia without diabetes and new-onset diabetes in COVID-19 is associated with a p...
Autores principales: | Singh, Awadhesh Kumar, Singh, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445123/ https://www.ncbi.nlm.nih.gov/pubmed/32853686 http://dx.doi.org/10.1016/j.diabres.2020.108382 |
Ejemplares similares
-
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes
por: Lin, Lijin, et al.
Publicado: (2021) -
At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
COVID-19, Hyperglycemia, and New-Onset Diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2021) -
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)